Physician profile
Robert Wayment
NPI 1295957280
$24,956.78
in general payments reported to CMS, 2019-2025
52 companies · $2,010 in 2025
The $2,010 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,787 · 2020: $4,952 · 2021: $4,041 · 2022: $1,982 · 2023: $1,356 · 2024: $828 · 2025: $2,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,911 · Education: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,911.03 |
| Education | $283.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,582.98 | 2019-2025 | Lithovue, Rezum Generator, Tria Firm |
| Astellas Pharma US INC | $1,561.81 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Abbvie INC. | $603.39 | 2019-2025 | Lupron Depot, Botox |
| Dendreon Pharmaceuticals LLC | $432.18 | 2019-2025 | Provenge |
| Pfizer INC. | $425.30 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $333.94 | 2023-2025 | Orgovyx, Gemtesa |
| Calyxo, INC. | $251.28 | 2024-2025 | Cvac Aspiration System |
| 180 Medical, INC. | $241.85 | 2019-2024 | |
| Endo Pharmaceuticals INC. | $239.82 | 2019-2024 | Xiaflex, Aveed |
| Rochester Medical Corporation | $226.90 | 2022 | |
| Janssen Biotech, INC. | $187.38 | 2019-2025 | Erleada |
| Allergan, INC. | $164.73 | 2019-2022 | |
| Myovant Sciences INC. | $150.31 | 2021-2022 | |
| Fujifilm Healthcare Americas Corporation | $132.61 | 2022 | |
| Philips North America LLC | $124.18 | 2022 |
Show all 51 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$337,113.75 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wayment listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.